Abstract

In recent years, special attention has been paid to the study of manufacturing processes that can precisely control the physicochemical properties of nanoparticles (NPs) and reduce batch-to-batch variability. Microfluidics has recently emerged as an advanced production method that can manage NP properties by monitoring the diffusion/emulsification mechanism. Pentamidine free base (PTM-B), a diamidine compound positively charged at physiological pH, has already been used as a model drug for incorporation into poly(lactic-co-glycolic acid) (PLGA) via an ion-pairing strategy using a conventional bulk production method. The same formulation was chosen to study the scaling-up process and preparation using the microfluidic technique. The formulation of PLGA NP loaded with PTM-B by the microfluidic technique was optimized by adding 1 % Lutrol F68 as a surfactant agent to stabilize the nanosuspension during the solvent diffusion in the microchannel of the chip, and then, washed away in the final suspension. A thorough investigation of process parameters (i.e., total flow rate, flow rate ratio) was conducted to obtain a monodisperse suspension characterized by a mean diameter of less than 150 nm. In addition, in vitro studies on mammalian cancer cell lines demonstrated the potential antitumor activity of PTM-B-loaded NPs prepared by the microfluidic technique.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.